
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
Feifei Cheng, Li Su, Cheng Qian
Oncotarget (2016) Vol. 7, Iss. 30, pp. 48832-48841
Open Access | Times Cited: 324
Feifei Cheng, Li Su, Cheng Qian
Oncotarget (2016) Vol. 7, Iss. 30, pp. 48832-48841
Open Access | Times Cited: 324
Showing 1-25 of 324 citing articles:
Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Dharambir Kashyap, Deeksha Pal, Riya Sharma, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 407
Dharambir Kashyap, Deeksha Pal, Riya Sharma, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 407
Liquid biopsy: a step forward towards precision medicine in urologic malignancies
Ashley Di Meo, Jenni Bartlett, Yufeng Cheng, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 305
Ashley Di Meo, Jenni Bartlett, Yufeng Cheng, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 305
Next-generation sequencing and its clinical application
Dahui Qin
Cancer Biology and Medicine (2019) Vol. 16, Iss. 1, pp. 4-10
Open Access | Times Cited: 229
Dahui Qin
Cancer Biology and Medicine (2019) Vol. 16, Iss. 1, pp. 4-10
Open Access | Times Cited: 229
Circulating Tumor DNA as Biomarkers for Cancer Detection
Xiao Han, Junyun Wang, Yingli Sun
Genomics Proteomics & Bioinformatics (2017) Vol. 15, Iss. 2, pp. 59-72
Open Access | Times Cited: 214
Xiao Han, Junyun Wang, Yingli Sun
Genomics Proteomics & Bioinformatics (2017) Vol. 15, Iss. 2, pp. 59-72
Open Access | Times Cited: 214
ctDNA as a cancer biomarker: A broad overview
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer
Critical Reviews in Oncology/Hematology (2020) Vol. 155, pp. 103109-103109
Open Access | Times Cited: 200
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer
Critical Reviews in Oncology/Hematology (2020) Vol. 155, pp. 103109-103109
Open Access | Times Cited: 200
Circulating tumor DNA as an early cancer detection tool
Andrea Campos-Carrillo, Jeffrey N. Weitzel, Prativa Sahoo, et al.
Pharmacology & Therapeutics (2019) Vol. 207, pp. 107458-107458
Open Access | Times Cited: 189
Andrea Campos-Carrillo, Jeffrey N. Weitzel, Prativa Sahoo, et al.
Pharmacology & Therapeutics (2019) Vol. 207, pp. 107458-107458
Open Access | Times Cited: 189
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
Vera Constâncio, Sandra P. Nunes, Rui Henrique, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 624-624
Open Access | Times Cited: 167
Vera Constâncio, Sandra P. Nunes, Rui Henrique, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 624-624
Open Access | Times Cited: 167
Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives
Marta Cristaldi, Rodolfo Mauceri, Olga Di Fede, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 148
Marta Cristaldi, Rodolfo Mauceri, Olga Di Fede, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 148
Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases
Anas Ahmad, Mohammad Imran, Haseeb Ahsan
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1630-1630
Open Access | Times Cited: 130
Anas Ahmad, Mohammad Imran, Haseeb Ahsan
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1630-1630
Open Access | Times Cited: 130
FGFR-TKI resistance in cancer: current status and perspectives
Sitong Yue, Yukun Li, Xiaojuan Chen, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 115
Sitong Yue, Yukun Li, Xiaojuan Chen, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 115
SE RS‐Based Biosensors Combined with Machine Learning for Medical Application**
Yan Ding, Yang Sun, Cheng Liu, et al.
ChemistryOpen (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Yan Ding, Yang Sun, Cheng Liu, et al.
ChemistryOpen (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
Xiaoling Wang, Lijuan Wang, Haihong Lin, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 27
Xiaoling Wang, Lijuan Wang, Haihong Lin, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 27
Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers
Mahima Mishra, Rubai Ahmed, Deepak Kumar Das, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 8, pp. 4740-4756
Open Access | Times Cited: 16
Mahima Mishra, Rubai Ahmed, Deepak Kumar Das, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 8, pp. 4740-4756
Open Access | Times Cited: 16
Application of liquid biopsy in precision medicine: opportunities and challenges
Junyun Wang, Shuang Chang, Guochao Li, et al.
Frontiers of Medicine (2017) Vol. 11, Iss. 4, pp. 522-527
Closed Access | Times Cited: 128
Junyun Wang, Shuang Chang, Guochao Li, et al.
Frontiers of Medicine (2017) Vol. 11, Iss. 4, pp. 522-527
Closed Access | Times Cited: 128
Pattern recognition for predictive, preventive, and personalized medicine in cancer
Tingting Cheng, Xianquan Zhan
The EPMA Journal (2017) Vol. 8, Iss. 1, pp. 51-60
Open Access | Times Cited: 125
Tingting Cheng, Xianquan Zhan
The EPMA Journal (2017) Vol. 8, Iss. 1, pp. 51-60
Open Access | Times Cited: 125
Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer’s Biomarkers
Diego Fernández-Lázaro, Juan Luis Garcı́a, Alberto Caballero-García, et al.
Diagnostics (2020) Vol. 10, Iss. 4, pp. 215-215
Open Access | Times Cited: 115
Diego Fernández-Lázaro, Juan Luis Garcı́a, Alberto Caballero-García, et al.
Diagnostics (2020) Vol. 10, Iss. 4, pp. 215-215
Open Access | Times Cited: 115
Precancer Atlas to Drive Precision Prevention Trials
Avrum Spira, Matthew B. Yurgelun, Ludmil B. Alexandrov, et al.
Cancer Research (2017) Vol. 77, Iss. 7, pp. 1510-1541
Open Access | Times Cited: 114
Avrum Spira, Matthew B. Yurgelun, Ludmil B. Alexandrov, et al.
Cancer Research (2017) Vol. 77, Iss. 7, pp. 1510-1541
Open Access | Times Cited: 114
The dawn of the liquid biopsy in the fight against cancer
Irma G. Domínguez-Vigil, Ana K. Moreno-Martínez, Julia Y. Wang, et al.
Oncotarget (2017) Vol. 9, Iss. 2, pp. 2912-2922
Open Access | Times Cited: 109
Irma G. Domínguez-Vigil, Ana K. Moreno-Martínez, Julia Y. Wang, et al.
Oncotarget (2017) Vol. 9, Iss. 2, pp. 2912-2922
Open Access | Times Cited: 109
CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR
S H Lee, Jihyeon Yu, G-H Hwang, et al.
Oncogene (2017) Vol. 36, Iss. 49, pp. 6823-6829
Open Access | Times Cited: 100
S H Lee, Jihyeon Yu, G-H Hwang, et al.
Oncogene (2017) Vol. 36, Iss. 49, pp. 6823-6829
Open Access | Times Cited: 100
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors
Pamela Pinzani, Valeria D’Argenio, Marzia Del Re, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 7, pp. 1181-1200
Open Access | Times Cited: 92
Pamela Pinzani, Valeria D’Argenio, Marzia Del Re, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 7, pp. 1181-1200
Open Access | Times Cited: 92
Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
David Pérez-Callejo, Atocha Romero, Mariano Provencio, et al.
Translational Lung Cancer Research (2016) Vol. 5, Iss. 5, pp. 455-465
Open Access | Times Cited: 90
David Pérez-Callejo, Atocha Romero, Mariano Provencio, et al.
Translational Lung Cancer Research (2016) Vol. 5, Iss. 5, pp. 455-465
Open Access | Times Cited: 90
Liquid biomarkers in melanoma: detection and discovery
Su Yin Lim, Jenny Lee, Russell J. Diefenbach, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 89
Su Yin Lim, Jenny Lee, Russell J. Diefenbach, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 89
Update on the types and usage of liquid biopsies in the clinical setting: a systematic review
Borros Arneth
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 86
Borros Arneth
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 86
Liquid Biopsy, ctDNA Diagnosis through NGS
Lin Chen, Xuzhu Liu, Bingyi Zheng, et al.
Life (2021) Vol. 11, Iss. 9, pp. 890-890
Open Access | Times Cited: 74
Lin Chen, Xuzhu Liu, Bingyi Zheng, et al.
Life (2021) Vol. 11, Iss. 9, pp. 890-890
Open Access | Times Cited: 74
Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 43-70
Closed Access | Times Cited: 46
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 43-70
Closed Access | Times Cited: 46